Immuno & Reacto of TF Trivalent Influenza Split Vaccine 2003/04 or of Std Formulation Influsplit SSW®/Fluarix™ 2003/04
Clinical trial NCT00731393 · COMPLETED
Trial details
- NCT number
- NCT00731393
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2004-08-01
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.